Discover insightful articles on health, wellness, and the habits that support a longer, stronger life.
Showing 1 to 12 of 38 articles
Key takeaways: Tissue Stiffness as a Driver: Extracellular matrix (ECM) stiffening, driven by abnormal collagen cross-linking, acts as a fundamental
A landmark 2026 analysis reveals that while hearing aids may not instantly reverse memory deficits, they significantly lower the long-term risk of cognitive decline and dementia in older adults.
At the AAIC 2026, new data showed Urolithin A successfully activates mitophagy in humans, offering hope for slowing cognitive decline and muscle frailty.
The first human doses of ER-100 have been administered, marking the inaugural clinical trial for cellular rejuvenation therapy. We examine how partial epigenetic reprogramming resets aging markers in retinal neurons and differentiate this restorative approach from traditional senolytic treatments.
As research pivots from treating late-stage dementia to preventing it, new tau-targeting vaccines like UNM's pT181 and Nuravax's DUVAX launch Phase 1 trials, marking a major advancement in cognitive longevity.
Researchers at MIT have engineered a microfluidic chip that compresses forty years of biological decline into ninety-six hours, offering a faster alternative to rodent trials for longevity drug development.
Pharmaceutical Metabolic Intervention Slows Epigenetic PaceIn a significant departure from traditional weight-loss or glycemic endpoints, recent clinical data h...
The Retina as a Window to Systemic Aging For the past decade, tracking biological aging has largely depended on invasive blood panels, epigenetic clocks, and me...
Novel Molecular Levers Redefine the 2026 Longevity Landscape As of July 2026, longevity science continues to mature from observational correlation to targeted m...
Moving Past Clearance: The Rise of Combination Immunotherapy and Regeneration As the longevity sector matures, early monotherapeutic approaches are being replac...
A Physical Reset for Systemic AgingAs the longevity sector advances, the conversation has increasingly centered on targeted pharmacological interventions and ce...
The Evolution of Senolytics: From Molecules to Cells As geroscience progresses through 2026, the therapeutic landscape for targeting cellular senescence is unde...
Join the mailing list
Be the first to know when fresh articles are published.